GeneDx Book Value Per Share from 2010 to 2024

WGSWW Stock

0.15 0.02 11.76%

GeneDx Holdings Book Value Per Share yearly trend continues to be fairly stable with very little volatility. Book Value Per Share is likely to outpace its year average in 2024. Book Value Per Share is the ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of GeneDx Holdings Corp according to its financial statements. View All Fundamentals

Book Value Per Share

First Reported

2010-12-31

Previous Quarter

9.37878838

Current Value

9.85

Quarterly Volatility

971.7 K

Credit Downgrade

Yuan Drop

Covid

Check GeneDx Holdings financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among GeneDx Holdings' main balance sheet or income statement drivers, such as Net Interest Income of 1.2 M, Interest Income of 3.1 M or Depreciation And Amortization of 31.3 M, as well as many indicators such as Price To Sales Ratio of 0.31, Dividend Yield of 0.0 or PTB Ratio of 0.52. GeneDx financial statements analysis is a perfect complement when working with GeneDx Holdings Valuation or Volatility modules.

Check out the analysis of GeneDx Holdings Correlation against competitors.

Latest GeneDx Holdings' Book Value Per Share Growth Pattern

Below is the plot of the Book Value Per Share of GeneDx Holdings Corp over the last few years. It is the ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements. GeneDx Holdings' Book Value Per Share historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in GeneDx Holdings' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 7.45 X

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Book Value Per Share

Timeline

GeneDx Book Value Per Share Regression Statistics

	Arithmetic Mean	(1,556,651)
	Coefficient Of Variation	(62.42)
	Mean Deviation	830,236
	Median	(2,122,721)
	Standard Deviation	971,668
	Sample Variance	944.1B
	Range	2.1M
	R-Value	0.77
	Mean Square Error	417.6B
	R-Squared	0.59
	Significance	0.0008
	Slope	166,788
	Total Sum of Squares	13.2T

GeneDx Book Value Per Share History

	2024	9.85
	2023	9.38
	2022	24.78
	2021	118.5

Other Fundumenentals of GeneDx Holdings Corp

Tangible Book Value Per Share

GeneDx Holdings Book Value Per Share component correlations

	Total Assets	Total Stockholder Equity	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Long Term Debt	Net Receivables	Total Liab	Net Invested Capital	Short Long Term Debt	Total Current Assets	Net Working Capital	Short Term Debt	Common Stock	Intangible Assets
Total Assets		1.0	-0.96	-0.3	-0.83	0.14	0.34	0.25	-1.0	1.0	0.41	0.68	0.59	0.21	-0.33	-0.51
Total Stockholder Equity	1.0		-0.96	-0.32	-0.82	0.17	0.3	0.24	-1.0	1.0	0.44	0.68	0.59	0.21	-0.3	-0.45
Current Deferred Revenue	-0.96	-0.96		0.03	0.95	0.03	-0.48	-0.44	0.97	-0.96	-0.25	-0.45	-0.36	-0.34	0.42	0.62
Net Debt	-0.3	-0.32	0.03		-0.27	-0.7	0.52	0.57	0.27	-0.3	-0.72	-0.9	-0.88	0.34	-0.35	-0.38
Retained Earnings	-0.83	-0.82	0.95	-0.27		0.29	-0.67	-0.56	0.85	-0.83	0.03	-0.17	-0.1	-0.39	0.56	0.75
Accounts Payable	0.14	0.17	0.03	-0.7	0.29		-0.89	0.04	-0.11	0.14	0.96	0.52	0.35	0.33	0.86	0.65
Long Term Debt	0.34	0.3	-0.48	0.52	-0.67	-0.89		0.1	-0.36	0.33	-0.72	-0.18	-0.06	-0.2	-0.97	-0.86
Net Receivables	0.25	0.24	-0.44	0.57	-0.56	0.04	0.1		-0.27	0.24	0.11	-0.38	-0.56	0.95	0.13	-0.31
Total Liab	-1.0	-1.0	0.97	0.27	0.85	-0.11	-0.36	-0.27		-1.0	-0.39	-0.65	-0.56	-0.22	0.35	0.52
Net Invested Capital	1.0	1.0	-0.96	-0.3	-0.83	0.14	0.33	0.24	-1.0		0.41	0.67	0.58	0.2	-0.32	-0.46
Short Long Term Debt	0.41	0.44	-0.25	-0.72	0.03	0.96	-0.72	0.11	-0.39	0.41		0.66	0.48	0.37	0.7	0.45
Total Current Assets	0.68	0.68	-0.45	-0.9	-0.17	0.52	-0.18	-0.38	-0.65	0.67	0.66		0.97	-0.24	0.03	-0.01
Net Working Capital	0.59	0.59	-0.36	-0.88	-0.1	0.35	-0.06	-0.56	-0.56	0.58	0.48	0.97		-0.46	-0.12	-0.05
Short Term Debt	0.21	0.21	-0.34	0.34	-0.39	0.33	-0.2	0.95	-0.22	0.2	0.37	-0.24	-0.46		0.41	-0.09
Common Stock	-0.33	-0.3	0.42	-0.35	0.56	0.86	-0.97	0.13	0.35	-0.32	0.7	0.03	-0.12	0.41		0.8
Intangible Assets	-0.51	-0.45	0.62	-0.38	0.75	0.65	-0.86	-0.31	0.52	-0.46	0.45	-0.01	-0.05	-0.09	0.8

Click cells to compare fundamentals

About GeneDx Holdings Financial Statements

GeneDx Holdings investors use historical fundamental indicators, such as GeneDx Holdings' Book Value Per Share, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in GeneDx Holdings. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Book Value Per Share	9.38	9.85
Tangible Book Value Per Share	2.28	2.39

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

Additional Tools for GeneDx Stock Analysis

When running GeneDx Holdings' price analysis, check to measure GeneDx Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GeneDx Holdings is operating at the current time. Most of GeneDx Holdings' value examination focuses on studying past and present price action to predict the probability of GeneDx Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GeneDx Holdings' price. Additionally, you may evaluate how the addition of GeneDx Holdings to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC